Drug Information and Pharmacotherapy

DI-039

PRELIMINARY STUDY TO ESTABLISH A NEW LINK BETWEEN HOSPITAL AND RETAIL PHARMACISTS TO FOLLOW UP PATIENTS TREATED WITH VITAMIN K ANTAGONISTS

DI-038

APPROPRIATE USE OF ANTI-DEMENTIA DRUGS IN THE ELDERLY: PRESCRIPTION PRACTICE EVALUATION IN NURSING HOMES

DI-037

TOXIC EPIDERMAL NECROLYSIS PROBABLY DUE TO CHEMOTHERAPY: A CASE REPORT

DI-036

INTRAVITREAL AFLIBERCEPT IN REFRACTORY AGE-RELATED MACULAR DEGENERATION

DI-035

SHOULD WE MAKE PATIENTS AND NURSES AWARE OF THEIR DRUG ADMINISTRATION PROBLEMS AND TRAINING NEEDS?

DI-032

ANTIRETROVIRAL THERAPY, ADHERENCE AND QUALITY OF LIFE IN OLDER HIV-PATIENTS WITH MODERATE-HIGH CARDIOVASCULAR RISK

DI-031

ANALYSIS OF ADVERSE DRUG REACTIONS REPORTED IN A UNIVERSITY HOSPITAL FOR PREVENTABILITY

DI-029

QUALITY OF INFORMATION ON MALE FERTILITY IN THE SUMMARY OF PRODUCT CHARACTERISTICS - CAUSE FOR CONCERN

DI-028

OFF-LABEL USE: A DESCRIPTIVE RETROSPECTIVE ANALYSIS.

DI-027

PEMETREXED USE IN PATIENTS WITH STAGE IV LUNG ADENOCARCINOMA WHO UNDERGO THYMIDYLATE SYNTHASE LEVEL INVESTIGATION

DI-026

IMPACT OF A TARGETED POLICY ON INTRAVENOUS OXYCODONE AND MORPHINE CONSUMPTION

DI-025

DIMETHYLFUMARATE FOR THE TREATMENT OF MULTIPLE SCLEROSIS : DOSING REGIMEN AND SAFETY DATA.

DI-024

OFF-LABEL USE OF GABAPENTIN AND PREGABALIN IN A TERTIARY HOSPITAL

DI-023

EFFECT OF DIFFERENT ANTIFUGAL EYE DROPS ON HUMAN CORNEAL CELLS IN VITRO

DI-022

NEW CHANCES IN MULTIPLE SCLEROSIS TREATMENT: SUSTAINED-RELEASE FAMPRIDINE

Pages